Pro Share Advisors LLC Rvl Pharmaceuticals PLC Transaction History

Pro Share Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$0.98 - $3.06 $13,165 - $41,108	-13,434 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.79 - $4.19 $6,040 - $9,071	2,165 Added 19.21%	13,434 $40,000
Q2 2021 Aug 13, 2021	SELL	$2.8 - $3.78 $2,195 - $2,963	-784 Reduced 6.5%	11,269 $34,000
Q1 2021 May 14, 2021	SELL	$3.26 - $4.84 $1,372 - $2,037	-421 Reduced 3.38%	12,053 $39,000
Q4 2020 Feb 09, 2021	BUY	$4.12 - $6.29 $2,504 - $3,824	608 Added 5.12%	12,474 $51,000
Q3 2020 Nov 13, 2020	BUY	$4.82 - $8.77 $4,010 - $7,296	832 Added 7.54%	11,866 $64,000
Q2 2020 Aug 03, 2020	BUY	$2.83 - $6.99 $31,226 - $77,127	11,034 New	11,034 $74,000
Q1 2020 May 15, 2020	SELL	$3.18 - $7.0 $39,114 - $86,100	-12,300 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$3.46 - $7.7 $42,558 - $94,710	12,300 New	12,300 $86,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.